{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T13:32:17Z","timestamp":1744291937319,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00066-022-02010-4","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T13:04:20Z","timestamp":1666184660000},"page":"396-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The trends and significance of SSTR PET\/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapy"],"prefix":"10.1007","volume":"199","author":[{"given":"Carola","family":"L\u00fctgendorf-Caucig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9584-2996","authenticated-orcid":false,"given":"Maciej","family":"Pelak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Flechl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Georg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Traub-Weidinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Marosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Haberler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Zechmeister-Machhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauritz","family":"Hermsmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Hug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Staudenherz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"2010_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis\u00a0DN, Perry\u00a0A, Reifenberger\u00a0G et\u00a0al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a\u00a0summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"2010_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.critrevonc.2008.01.010","volume":"67","author":"C Marosi","year":"2008","unstructured":"Marosi\u00a0C, Hassler\u00a0M, Roessler\u00a0K et\u00a0al (2008) Meningioma. Crit Rev Oncol Hematol 67:153\u2013171","journal-title":"Crit Rev Oncol Hematol"},{"key":"2010_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-3-319-21359-0_6","volume":"43","author":"HM Mehdorn","year":"2016","unstructured":"Mehdorn\u00a0HM (2016) Intracranial meningiomas: a 30-year experience and literature review. Adv Tech Stand Neurosurg 43:139\u2013184. https:\/\/doi.org\/10.1007\/978-3-319-21359-0_6","journal-title":"Adv Tech Stand Neurosurg"},{"key":"2010_CR4","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner\u00a0R, Stavrinou\u00a0P, Jenkinson\u00a0MD et\u00a0al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23:1821\u20131834. https:\/\/doi.org\/10.1093\/neuonc\/noab150","journal-title":"Neuro Oncol"},{"key":"2010_CR5","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.2967\/jnumed.117.191932","volume":"58","author":"WG Kunz","year":"2017","unstructured":"Kunz\u00a0WG, Jungblut\u00a0LM, Kazmierczak\u00a0PM et al (2017) Improved detection of transosseous meningiomas using 68Ga-DOTATATE PET\/CT compared with contrast-enhanced MRI. J\u00a0Nucl Med 58:1580\u20131587. https:\/\/doi.org\/10.2967\/jnumed.117.191932","journal-title":"J Nucl Med"},{"key":"2010_CR6","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00259-019-04591-2","volume":"47","author":"KA Kessel","year":"2020","unstructured":"Kessel\u00a0KA, Weber\u00a0W, Yakushev\u00a0I et al (2020) Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome. Eur J Nucl Med Mol Imaging 47:1391\u20131399. https:\/\/doi.org\/10.1007\/s00259-019-04591-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2010_CR7","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1093\/neuonc\/nox112","volume":"19","author":"N Galldiks","year":"2017","unstructured":"Galldiks\u00a0N, Albert\u00a0NL, Sommerauer\u00a0M et\u00a0al (2017) PET imaging in patients with meningioma\u2014Report of the RANO\/PET Group. Neuro Oncol 19:1576\u20131587. https:\/\/doi.org\/10.1093\/neuonc\/nox112","journal-title":"Neuro Oncol"},{"key":"2010_CR8","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.3390\/CANCERS13184707","volume":"13","author":"MJ Pelak","year":"2021","unstructured":"Pelak\u00a0MJ, Flechl\u00a0B, Mumot\u00a0M et al (2021) The value of SSTR2 receptor-targeted PET\/CT in proton irradiation of grade I meningioma. Cancers 13:4707. https:\/\/doi.org\/10.3390\/CANCERS13184707","journal-title":"Cancers"},{"key":"2010_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ijrobp.2005.12.006","volume":"65","author":"S Milker-Zabel","year":"2006","unstructured":"Milker-Zabel\u00a0S, Zabel-du Bois\u00a0A, Henze\u00a0M et al (2006) Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys 65:222\u2013227. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.12.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2010_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1102\/1470-7330.2008.0010","volume":"8","author":"LF de Geus-Oei","year":"2008","unstructured":"de Geus-Oei\u00a0LF, Oyen\u00a0WJG (2008) Predictive and prognostic value of FDG-PET. Cancer Imaging 8:70\u201380. https:\/\/doi.org\/10.1102\/1470-7330.2008.0010","journal-title":"Cancer Imaging"},{"key":"2010_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s41824-019-0066-2","volume":"3","author":"F Giammarile","year":"2019","unstructured":"Giammarile\u00a0F, Castellucci\u00a0P, Dierckx\u00a0R et al (2019) Non-FDG PET\/CT in diagnostic oncology: a\u00a0pictorial review. Eur J Hybrid Imaging 3:20. https:\/\/doi.org\/10.1186\/s41824-019-0066-2","journal-title":"Eur J Hybrid Imaging"},{"key":"2010_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/neuonc\/noy137","volume":"21","author":"RY Huang","year":"2019","unstructured":"Huang\u00a0RY, Bi\u00a0WL, Weller\u00a0M et al (2019) Proposed response assessment and endpoints for meningioma clinical trials: report from the response assessment in neuro-oncology working group. Neuro Oncol 21:26\u201336. https:\/\/doi.org\/10.1093\/neuonc\/noy137","journal-title":"Neuro Oncol"},{"key":"2010_CR13","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche\u00a0C, Orlhac\u00a0F, Boughdad\u00a0S et\u00a0al (2018) Lifex: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res 78:4786\u20134789. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0125","journal-title":"Cancer Res"},{"key":"2010_CR14","doi-asserted-by":"publisher","first-page":"17024","DOI":"10.1038\/s41598-020-73237-3","volume":"10","author":"Y Toyama","year":"2020","unstructured":"Toyama\u00a0Y, Hotta\u00a0M, Motoi\u00a0F et al (2020) Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer. Sci Rep 10:17024. https:\/\/doi.org\/10.1038\/s41598-020-73237-3","journal-title":"Sci Rep"},{"key":"2010_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2967\/jnumed.114.149120","volume":"56","author":"W Rachinger","year":"2015","unstructured":"Rachinger\u00a0W, Stoecklein\u00a0VM, Terpolilli\u00a0NA et al (2015) Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue. J\u00a0Nucl Med 56:347\u2013353. https:\/\/doi.org\/10.2967\/jnumed.114.149120","journal-title":"J Nucl Med"},{"key":"2010_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/jon.12632","volume":"29","author":"J Ivanidze","year":"2019","unstructured":"Ivanidze\u00a0J, Roytman\u00a0M, Lin\u00a0E et al (2019) Gallium-68 DOTATATE PET in the evaluation of intracranial meningiomas. J\u00a0Neuroimaging 29:650\u2013656. https:\/\/doi.org\/10.1111\/jon.12632","journal-title":"J Neuroimaging"},{"key":"2010_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1748-717X-4-56","volume":"4","author":"B Gehler","year":"2009","unstructured":"Gehler\u00a0B, Paulsen\u00a0F, \u00d6ks\u00fcz\u00a0MT et al (2009) 68Ga]-DOTATOC-PET\/CT for meningioma IMRT treatment planning. Radiat Oncol 4:56\u201356. https:\/\/doi.org\/10.1186\/1748-717X-4-56","journal-title":"Radiat Oncol"},{"key":"2010_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13014-018-1056-4","volume":"13","author":"B Zollner","year":"2018","unstructured":"Zollner\u00a0B, Ganswindt\u00a0U, Maih\u00f6fer\u00a0C et al (2018) Recurrence pattern analysis after [68Ga]-DOTATATE-PET\/CT-planned radiotherapy of high-grade meningiomas. Radiat Oncol 13:110. https:\/\/doi.org\/10.1186\/s13014-018-1056-4","journal-title":"Radiat Oncol"},{"key":"2010_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4103\/ijnm.IJNM_98_19","volume":"34","author":"M Pelak","year":"2019","unstructured":"Pelak\u00a0M, D\u2019Amico\u00a0A (2019) The prognostic value of pretreatment gallium-68 DOTATATE positron emission tomography\/computed tomography in irradiated non-benign meningioma. Indian J Nucl Med 34:278\u2013283. https:\/\/doi.org\/10.4103\/ijnm.IJNM_98_19","journal-title":"Indian J Nucl Med"},{"key":"2010_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1210\/jcem.74.3.1346787","volume":"74","author":"JW Koper","year":"1992","unstructured":"Koper\u00a0JW, Markstein\u00a0R, Kohler\u00a0C et\u00a0al (1992) Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J\u00a0Clin Endocrinol Metab 74:543\u2013547. https:\/\/doi.org\/10.1210\/jcem.74.3.1346787","journal-title":"J Clin Endocrinol Metab"},{"key":"2010_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/02841860802314746","volume":"48","author":"T Zhou","year":"2009","unstructured":"Zhou\u00a0T, Xiao\u00a0X, Xu\u00a0B et al (2009) Overexpression of SSTR2 inhibited the growth of SSTR2-positive tumors via multiple signaling pathways. Acta Oncol 48:401\u2013410. https:\/\/doi.org\/10.1080\/02841860802314746","journal-title":"Acta Oncol"},{"key":"2010_CR22","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/NEUONC\/NOW001","volume":"18","author":"M Sommerauer","year":"2016","unstructured":"Sommerauer\u00a0M, Burkhardt\u00a0J\u2011K, Frontzek\u00a0K et al (2016) 68Gallium-DOTATATE PET in meningioma: a reliable predictor of tumor growth rate? Neuro Oncol 18:1021. https:\/\/doi.org\/10.1093\/NEUONC\/NOW001","journal-title":"Neuro Oncol"},{"key":"2010_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2967\/jnumed.109.066662","volume":"51","author":"D Campana","year":"2010","unstructured":"Campana\u00a0D, Ambrosini\u00a0V, Pezzilli\u00a0R et al (2010) Standardized uptake values of68Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. J\u00a0Nucl Med 51:353\u2013359. https:\/\/doi.org\/10.2967\/jnumed.109.066662","journal-title":"J Nucl Med"},{"key":"2010_CR24","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2967\/jnumed.119.240143","volume":"61","author":"EA Carlsen","year":"2020","unstructured":"Carlsen\u00a0EA, Johnbeck\u00a0CB, Binderup\u00a0T et al (2020) 64Cu-DOTATATE PET\/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms. J\u00a0Nucl Med 61:1491\u20131497. https:\/\/doi.org\/10.2967\/jnumed.119.240143","journal-title":"J Nucl Med"},{"key":"2010_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/brainsci11030375","volume":"11","author":"F Barone","year":"2021","unstructured":"Barone\u00a0F, Inserra\u00a0F, Scalia\u00a0G et al (2021) 68\u202fga-dotatoc pet\/ct follow up after single or hypofractionated gamma knife icon radiosurgery for meningioma patients. Brain Sci 11:375. https:\/\/doi.org\/10.3390\/brainsci11030375","journal-title":"Brain Sci"},{"key":"2010_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13014-021-01875-6","volume":"16","author":"E Kowalski","year":"2021","unstructured":"Kowalski\u00a0E, Khairnar\u00a0R, Gryaznov\u00a0AA et al (2021) 68Ga-DOTATATE PET-CT as a\u00a0tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas. Radiat Oncol 16:151. https:\/\/doi.org\/10.1186\/s13014-021-01875-6","journal-title":"Radiat Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-02010-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-022-02010-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-02010-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T23:02:30Z","timestamp":1679526150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-022-02010-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2010"],"URL":"https:\/\/doi.org\/10.1007\/s00066-022-02010-4","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"type":"print","value":"0179-7158"},{"type":"electronic","value":"1439-099X"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.\u00a0L\u00fctgendorf-Caucig, M.\u00a0Pelak, B.\u00a0Flechl, P.\u00a0Georg, P.\u00a0Fossati, M.\u00a0Stock, T.\u00a0Traub-Weidinger, C.\u00a0Marosi, C.\u00a0Haberler, G.\u00a0Zechmeister-Machhart, L.\u00a0Hermsmeyer, E.\u00a0Hug, and A.\u00a0Staudenherz declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained on 22.16.2016 from the regional ethics committee of Lower Austria, approval no. EK Nr GS1-EK-4\/350-2015. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all individual participants included in the study, including consent to publish anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}